SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-019931
Filing Date
2020-10-26
Accepted
2020-10-26 14:39:41
Documents
1
Period of Report
2020-10-16

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 4200
  Complete submission text file 0001493152-20-019931.txt   6173
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Reporting) CIK: 0001493215 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39614 | Film No.: 201260305

Mailing Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10019
Business Address
WONG RODERICK (Reporting) CIK: 0001493280 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39614 | Film No.: 201260306

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Issuer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)